Webster W P, Mandel S R, Strike L E, Penick G D, Griggs T R, Brinkhous K M
Am J Physiol. 1976 May;230(5):1342-8. doi: 10.1152/ajplegacy.1976.230.5.1342.
Transplantation experiments were utilized to study the possible sites of synthesis of von Willebrand factor (vWF) and factor VIII (F VIII) activities. Three normal kidney and two normal liver allografts were implanted into five swine with von Willebrand's disease (vWD) that survived for 1,6, and 7, and 4 and 9 days, respectively. The correction of the multiple hemostatic defects of vWD by organ transplantation was evaluated using the F VIII procoagulant activity, bleeding time, and platelet aggregating factor (PAF) levels; i.e., vWF levels. Normal kidney allografts produced no changes in the bleeding times or increases in F VIII or PAF. Transfusions for surgical hemostasis produced transient increases in F VIII and PAF. In animals receiving normal liver allografts, the levels of F VIII exceeded 100%, PAF was increased, and sustained correction of the bleeding time and maintenance of hemostasis was observed. These data suggest that the kidney is incapable of synthesizing either the vWF or the F VIII and that cells contained in the liver, possibly the endothelial cells, are one of the sites of synthesis of these factors.
利用移植实验研究血管性血友病因子(vWF)和凝血因子VIII(F VIII)活性的可能合成部位。将三个正常肾脏同种异体移植物和两个正常肝脏同种异体移植物分别植入五头患有血管性血友病(vWD)的猪体内,这些猪分别存活了1天、6天、7天、4天和9天。使用F VIII促凝活性、出血时间和血小板聚集因子(PAF)水平,即vWF水平,评估通过器官移植对vWD多种止血缺陷的纠正情况。正常肾脏同种异体移植物未引起出血时间变化,也未使F VIII或PAF增加。用于手术止血的输血使F VIII和PAF产生短暂升高。在接受正常肝脏同种异体移植物的动物中,F VIII水平超过100%,PAF增加,观察到出血时间持续纠正且止血得以维持。这些数据表明,肾脏无法合成vWF或F VIII,肝脏中的细胞(可能是内皮细胞)是这些因子的合成部位之一。